Patents Examined by Michael Barker
  • Patent number: 10967018
    Abstract: A method for the extraction and isolation of the terpene and isoprenoid compounds from plant material, followed by a centrifugal force induced selective crystallization of isoprenoids resulting in a separation of terpene and isoprenoid fractions. This this method is suitable for the extraction of cannabinoids from Cannabis and the enrichment tetrahydrocannabinolic acid and reduction of tetrahydrocannabinol in an extract.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: April 6, 2021
    Assignee: Concentrated Consulting Group, LLC
    Inventor: Bradley Lee Robertson
  • Patent number: 10967032
    Abstract: The present invention relates to a hypertension treatment. More particularly, the present invention relates to combination of four herbs' extract including 95% ethanolic extract of U. rhynchophylla (UR95), 95% ethanolic extract of P. thomsonii (PT95), 95% ethanolic extract of P. notoginseng (PN95), and 50% ethanolic extract of A. orientale (AO50) in particular range of ratio (known as F1 ratio), and all the raw herbs were then extracted in total by using 50% ethanol (known as F1-2) for use in a medicament for treating hypertension and hypertension-related complications and a composition thereof.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: April 6, 2021
    Inventor: Mun Fei Yam
  • Patent number: 10960057
    Abstract: The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The invention also relates to the combination of sulforaphane or a derivative thereof and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present invention also relates to the combination of a broccoli extract or powder and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present provides compositions and methods relating to these combinations.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: March 30, 2021
    Inventors: Brian Cornblatt, Grace Cornblatt, Anton Bzhelyansky, Robert Henderson
  • Patent number: 10960044
    Abstract: The present disclosure relates to the field of health care products, disclosing a powder made from inulin, FOLIUM CYCLOCARYA PALIURUS, RHIZOMA DIOSCOREA OPPOSITE, RADIX ASTRAGALUS MEMBRANACEUS, CAULIS DENDROBIUM and RADIX ET RHIZOMA SALVIA MILTIORRHIZA. The raw materials of the powder are all from natural Chinese herbal medicine without addition of excipient. In addition, dosage required for the powder is small; it can be directly dissolved in water for taking; it is soluble in cold water and can be absorbed quickly. The method for preparing the powder in the present disclosure is simple and suitable for large-scale production. Also, it is easy to be carried. The powder obtained has a good stability and long storage time. Experiments show that the powder of the present disclosure has greatly hypoglycemic and hypolipidemic effects, therefore can be used to prepare the health care foods having hypoglycemic and hypolipidemic effect.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: March 30, 2021
    Inventors: Fang Lv, Hongwei Zhao, Qingtao Tang
  • Patent number: 10952953
    Abstract: The present invention relates to a composition of aqueous gel type comprising from 7.5% to 13.5% by dry weight, relative to its total weight, of at least one modified crosslinked C1-C4 carboxyalkyl starch and at least one C2-C5 monoalcohol. A composition according to the invention is in particular of use as a skin cleansing mask, in particular a face cleansing mask. The invention also relates to a process for the preparation thereof, to a process for cosmetic treatment of keratin materials and to a cosmetic process for cleansing a keratin material.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: March 23, 2021
    Assignee: L'OREAL
    Inventors: Emmanuelle Camblong, Céline Marcq, Valérie Page
  • Patent number: 10946059
    Abstract: Various embodiments relate to formulations containing an extract of Alpinia galanga; a method of improving cognitive performance by administering an extract of Alpinia galanga; and a process for preparing an extract of Alpinia galanga.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: March 16, 2021
    Assignee: Enovate Biolife LLC
    Inventors: Jayesh Chaudhary, Latha Chaudhary, Sachin Dighe, Shalini Srivastava
  • Patent number: 10945991
    Abstract: The present disclosure discloses an extract of Antrodia cinnamomea and pharmaceutical application thereof. As confirmed by the researches of the present disclosure, said extract of Antrodia cinnamomea is able to decrease the activities of hepatic stellate cell and therefore obtain the efficacy of liver fibrosis prevention and/or treatment. Accordingly, the present disclosure discloses a novel pharmaceutical application of Antrodia cinnamomea and provides an alternative prevention and/or treatment regime of liver fibrosis for the field.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: March 16, 2021
    Assignee: COJET BIOTECH INC.
    Inventors: Yu-Lung Wang, Judy Chen
  • Patent number: 10946057
    Abstract: The present invention is based on the surprising antiseptic nature of chlorhexidine when combined with essential oils. It has been found that chlorhexidine, combined with an essential oil, is surprisingly effective at penetrating the skin surface and providing an antiseptic effect within the skin. It has also been found that a combination of chlorhexidine and eucalyptus oil is surprisingly effective as an antimicrobial against Staphylococcus epidermidis.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: March 16, 2021
    Inventors: Tony Worthington, Tarja Karpanen
  • Patent number: 10940457
    Abstract: The disclosure provides methods and reagents for removing pesticides or pesticide residues from plant matter such as cannabis plant matter. The method uses adsorption on bentonite (bentonite scrubbing).
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: March 9, 2021
    Assignee: Capna Intellectual Property Capital, LLC
    Inventor: Erwin Sibal
  • Patent number: 10939686
    Abstract: The present invention is directed to methods of controlling pathogenic fungi comprising applying sabadilla oil.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: March 9, 2021
    Assignee: McLaughlin Gormley King Company
    Inventors: Robert A. Suranyi, Darrick David Unger
  • Patent number: 10933013
    Abstract: Oral hygiene compositions including pharmacologically active ingredients extracted from one or more species of plants (or interbred strains thereof) in the Cannabis genus. In an embodiment, an extraction process may include techniques to maximize the ratio of tetrahydrocannabinolic acid (“THCA”) to tetrahydrocannabinaol (THC) in the essential oil extract, in order to maximize the presence of the non-euphoric THCA. In an embodiment, a mouthwash composition is provided. In an embodiment, an essential oil extract may be applied neat. In an embodiment, an essential oil extract may be mixed with food grade carriers (e.g. glycerol, or vegetable oil) and/or diluents (e.g. water, ethanol), and used as mouth rinse, in a conventional rinse and spit fashion. In an embodiment, an essential oil extract may be mixed with food grade carries and/or diluents and used as an ingestible composition, in a rise and swallow fashion.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: March 2, 2021
    Inventor: Ethan D Dean
  • Patent number: 10933033
    Abstract: A composition for preventing or reducing nephrotoxicity, and use thereof are provided, the composition including a Hypoxylon truncatum extract or an active component thereof.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: March 2, 2021
    Inventors: Jungyeob Ham, Young Tae Park, Taejung Kim, Young seok Kim, Pilju Choi, Kyusun Kim, SeonJun Choi, BongGeun Song, Kisung Kang, Buyng Su Hwang, Dahae Lee, Jihoon Song
  • Patent number: 10925919
    Abstract: Provided is a material effective for improving the activity of nerves in the brain or for preventing or ameliorating brain dysfunction. An agent for activating astrocyte glucose metabolism, brain nerve cells activating agent, a brain hypofunction suppressing agent, a brain function improving agent, or an agent for preventing or ameliorating brain dysfunction comprising, as an active ingredient, one or more selected from the group consisting of hydrophobic solvent extracts of tien-cha, rooibos, grape and black tea.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: February 23, 2021
    Assignee: Kao Corporation
    Inventors: Keiko Ishida, Koichi Misawa, Kohjiro Hashizume
  • Patent number: 10918689
    Abstract: The present application discloses a solid beverage for conditioning allergic constitution. The solid beverage comprises the following components in parts by weight: 18-45 parts of smoked plum, 10-30 parts of perilla, 18-45 parts of lilium brownii, 10-30 parts of purslane, 10-30 parts of coix seed, 10-30 parts of semen hoveniae, 7-20 parts of dahurian angelica, 15-40 parts of dextrin, 9-23 parts of maltodextrin, 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of allergic constitution, and the production process thereof is suitable for industrial mass production.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: February 16, 2021
    Inventor: Zhonghua Ci
  • Patent number: 10918676
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: February 16, 2021
    Assignee: Aimmune Therapeutics, Inc.
    Inventor: Howard V. Raff
  • Patent number: 10912305
    Abstract: The use is described of a chestnut tannin extract (Castanea sativa Mill.), as a non-phytotoxic acaricidal agent, alone or in a mixture with other active principles having an acaricidal activity.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: February 9, 2021
    Assignee: SADEPAN CHIMICA S.R.L.
    Inventors: Gianluca Costa, Dario Gozzi, Mattia Ferrante, Pierluigi Zambelli
  • Patent number: 10912324
    Abstract: Disclosed is a food composition which promotes lymphatic circulation in the body to improve the environment around the cells and to help normal metabolism of the cells. The food composition according to the present invention includes cnidium, maple syrup, dried bigarade orange, bambusae succus, kalopanax and coix in the form of powder, liquid or extract.
    Type: Grant
    Filed: April 22, 2018
    Date of Patent: February 9, 2021
    Inventor: Heong Jun Yu
  • Patent number: 10905724
    Abstract: A method for decreasing proliferation of cancer cells comprises the steps of administering a sensitizer. Sensitizers can include selenium, fish oil, and a combination of selenium and fish oil to a cancer cell. The method contemplates that the selenium and fish oil are administered in an amount effective to respectively increase the sensitivity of the cancer cells, and the administration of the combination of selenium and fish oil are administered in an amount effective to synergistically increase the sensitivity of the cancer cells more than the selenium or the fish oil alone. The method additionally exposes cancer cells to temperatures in excess of 37° C.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: February 2, 2021
    Inventor: Houn Simon Hsia
  • Patent number: 10905748
    Abstract: A composition and method of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal involves administering ovotransferrin to the reproductive tract of the animal. The ovotransferrin administration protects against and treats reproductive tract infection, while protecting against and treating reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: February 2, 2021
    Assignee: VETS PLUS, INC.
    Inventors: Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava, Rajiv Lall
  • Patent number: 10905732
    Abstract: A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: February 2, 2021
    Assignee: 4Life Patents, LLC
    Inventors: Calvin W. McCausland, Brent Vaughan, David Lisonbee, William J. Hennen